Letter to the Editor: Survival in placebo-treated patients with severe alcohol-associated hepatitis
- PMID: 36815362
- DOI: 10.1097/HEP.0000000000000336
Letter to the Editor: Survival in placebo-treated patients with severe alcohol-associated hepatitis
Comment on
-
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.Hepatology. 2022 Oct;76(4):1058-1068. doi: 10.1002/hep.32478. Epub 2022 Jun 2. Hepatology. 2022. PMID: 35340032 Free PMC article. Clinical Trial.
References
-
- Szabo G, Mitchell M, Mcclain CJ, Srinivasan D, Barton B, McCullough AJ, et al. IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis. Hepatology. 2022;76:1058–68.
-
- Lucey MR, Thursz MR. We need a new approach to clinical trials in alcohol-associated hepatitis: is there a lesson in RECOVERY? Hepatology. 2022;76:909–10.
-
- Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619–28.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
